library.onepin.app/bpc-157-arginate Peptide Education Library
Education only, not medical advice 21+ Every dose is an example to finalize with a licensed provider
Repair & Recovery Gastric PentadecapeptideNot FDA-approved · research compound

BPC-157 Arginate

BPC-157 Arginate Salt

250-500mcg SubQ 1-2x daily
250-500 mcg Oral 2x Daily
Tissue RepairCytoprotectiveStable Salt Form

BPC-157 Arginate (also called BPC-157 Arginine Salt) is a stable salt form of the gastric pentadecapeptide BPC-157, where the peptide is complexed with L-arginine. This formulation was developed to improve the stability and oral bioavailability of BPC-157, as the arginine salt form is more resistant to degradation in the gastrointestinal tract.

Quick Start
Route
Subcutaneous (SubQ) or Oral
Start low
250-500mcg SubQ
Frequency
1-2x daily
Timing
No fasting required (oral: empty stomach preferred)

Same timing as standard BPC-157. Can be taken any time. Empty stomach for oral dosing.

Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.

Tiered Protocols · lowest first
Conservative start
250-500mcg · Subcutaneous (SubQ) or Oral · 1-2x daily
conservative starter
250-500mcg
1-2x daily
Standard
Gastric Healing (Oral)
250-500 mcg · Oral · 2x Daily
animal study · Sikiric et al. 2011 (Curr Pharm Des, 17:1612-32; PMID 21548867)
Arginate salt provides significantly higher stability in gastric acid compared to the standard acetate form. Human exposure data exists at Phase 1 level: safety and blood levels in 42 healthy volunteers (NCT02637284). No completed human trial has shown BPC-157 heals anything. Every efficacy claim still rests on rat studies.
250-500 mcg
2x Daily
Reconstitution CalculatorU-100
050100u
Draw to
units
01

How it works

Identical mechanism to standard BPC-157: upregulates VEGF and eNOS for angiogenesis, modulates the NO system, promotes FAK-paxillin pathway for cell migration, and increases GH receptor expression. The arginine salt form provides a counterion that stabilizes the peptide structure, particularly in low-pH environments like the stomach. Arginine itself is a nitric oxide precursor, which may provide a minor additive benefit to BPC-157's own NO-modulating effects.

02

What to expect

Early
Days 1–7

Days 1-7: Reduced inflammation and pain at injury site. Gut issues may show early improvement. Same rapid onset as standard BPC-157.

03

Evidence

HumanNo published trials
AnimalStrong
In-vitroPresent

Claims we could not support

No abstract we checked supports these for this molecule at this route. That is not the same as saying they are false — it marks where the evidence is missing.

Dose/route: 250-500 mcg oral or SubQ 1-2x/day. No exact-molecule PubMed/PMC abstract was found for either route.

Mechanism. PubMed returned no exact BPC-157 arginate/arginine-salt abstract. Parent BPC-157 evidence cannot be transferred to the arginate salt.

Primary safety concern. No exact-molecule human or animal abstract was found; parent-compound safety cannot be substituted.

04

The honest take

Arginate form is significantly better than standard BPC-157

Partly true

Partially supported. The arginate salt form does show improved acid stability, which is meaningful for oral administration. For injectable use, the difference is likely negligible since both forms deliver the same active peptide into the bloodstream.

Only the arginate form works orally
Overstated

Overstated. Standard BPC-157 (acetate) is already acid-stable due to its amino acid sequence. The arginate form may provide incrementally better oral bioavailability, but standard BPC-157 has extensive oral efficacy data in animal studies.

05

Interactions & stacking

Two different questions: what is documented about running these together, and what is documented about drawing them into the same syringe. A good pharmacological partner can still have to be pinned separately.

Documented together

GHK-CuBPC tissue repair + GHK-Cu collagen remodeling.
KPVBPC targets tissue repair, KPV targets inflammation. Gut healing combo.
TB-500Wolverine Stack: BPC drives angiogenesis/NO, TB drives actin/cell migration.

Keep separate

CJC-1295 with DACDAC maleimide group may react with BPC. Pin separately.
NAD+Acidic pH of NAD+ can denature BPC-157.

Check any specific pair in the Stack & Interaction Checker, which answers both questions separately. Absence of a documented conflict is not evidence of safety.

06

Side effects & safety

Commonly reported

  • Mild injection site redness (resolves quickly)
  • Occasional lightheadedness post-injection
  • Mild GI changes during gut healing phase

Less common & notes

  • Same exceptionally favorable safety profile as standard BPC-157.
  • No LD50 established in animal studies.
  • Long-term human safety data does not exist for either form.
07

Pharmacokinetics

Illustrative plasma concentration · 1.1 h
Half-life
~2 min

(plasma), ~4-6h biological activity

Peak · Tmax

Rapid (minutes)

Elimination
~20h
Bioavailability
~100%

SubQ, potentially improved oral vs acetate form

Duration of action
4-6 hours

Tissue repair signaling via VEGF/eNOS persists well beyond plasma half-life

Clearance

Enzymatic degradation (peptidases); rapid plasma clearance with prolonged tissue-level activity

Storage. Reconstitute with bacteriostatic water for injection. Store refrigerated at 2-8C. Same stability as standard BPC-157 - 28-30 days after reconstitution. For oral use, some users dissolve in water and drink. Do not freeze after reconstitution.

08

Regulatory status

Not FDA-approved for any indication. Same regulatory status as standard BPC-157 - available through compounding pharmacies and research suppliers. All human use is experimental/off-label.

Put it to work

Calculate, log & track

Open BPC-157 Arginate straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.

Open BPC-157 Arginate in the app →

Go deeper

The guide & community

The complete BPC-157 Arginate walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.

Join the community ↗
Open in app Community

Track it in OnePin. Log vials, draws, and protocols in the app.